Heart surgery kidney shield? stomach drug tested for prevention
NCT ID NCT06154226
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether giving the acid-reducing drug pantoprazole during heart surgery could prevent acute kidney injury, a common complication. One hundred adults at moderate-to-high risk for kidney damage were randomly assigned to receive either pantoprazole or another acid reducer (famotidine). Researchers measured kidney injury markers in urine to see if pantoprazole offered better protection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The University of Texas Health Science Center at Houston
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Ultrasound-Guided diuretic strategy may boost kidney recovery after cardiac surgery
- A simple urine test and a smart alert may help predict kidney failure in sick kids
- The hidden price tag of kidney injury after heart surgery
- A common amino acid may shield kidneys after heart surgery — a massive analysis puts it to the test
- Urine biomarkers may spot kidney damage before standard tests do
- Urine test after a single dose of furosemide may spot kidney danger in ICU patients